No justification behind such a rush, given small-animalThink of it for a second.
Just like it didn't made sense when this stock had absolutely no reaction on NMIBC Ph. 1 P#5 and P#6 given the outstanding data in human in 2017, 20118, 2019, the recent drop to 0.125$ was a manipulated one.
And Friday's reaction (and the one coming up today as per the L2 data) in terms of volume and share price spike, given how far we are from even a Ph. 1 alone, simply shows that this is an artificial push, on that news alone. So there's absolutely no fundamental that justifies such an immediate rush at the opening this morning. But we'll see such a rush as this TMX-V allows for manipulatation. Just like SONA went from 0.03$ to 15$ now back to 3$.
It would be much pleasant to see more rationale behind stock movements. But we'll take this well deserve one, though superficial.
Theralase plans to commence an in-vivo small animal study later this year at another facility equipped to handle SARS-CoV-2 viruses and if successful commence human clinical studies in 2021, subject to suitable financing.